nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—Neuralgia—Thalidomide—leprosy	0.0349	0.0349	CcSEcCtD
Alfuzosin—Cholestasis—Thalidomide—leprosy	0.0319	0.0319	CcSEcCtD
Alfuzosin—Arthropathy—Thalidomide—leprosy	0.0267	0.0267	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Dapsone—leprosy	0.026	0.026	CcSEcCtD
Alfuzosin—Sinusitis—Dapsone—leprosy	0.0249	0.0249	CcSEcCtD
Alfuzosin—Hepatocellular injury—Thalidomide—leprosy	0.0242	0.0242	CcSEcCtD
Alfuzosin—Pharyngitis—Dapsone—leprosy	0.0236	0.0236	CcSEcCtD
Alfuzosin—Neuropathy—Thalidomide—leprosy	0.0228	0.0228	CcSEcCtD
Alfuzosin—Injury—Thalidomide—leprosy	0.0191	0.0191	CcSEcCtD
Alfuzosin—Vertigo—Dapsone—leprosy	0.0186	0.0186	CcSEcCtD
Alfuzosin—Atrial fibrillation—Thalidomide—leprosy	0.0186	0.0186	CcSEcCtD
Alfuzosin—Arthritis—Thalidomide—leprosy	0.0181	0.0181	CcSEcCtD
Alfuzosin—Osteoarthritis—Thalidomide—leprosy	0.0176	0.0176	CcSEcCtD
Alfuzosin—Tachycardia—Dapsone—leprosy	0.0165	0.0165	CcSEcCtD
Alfuzosin—Orthostatic hypotension—Thalidomide—leprosy	0.0161	0.0161	CcSEcCtD
Alfuzosin—Breast disorder—Thalidomide—leprosy	0.0159	0.0159	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Thalidomide—leprosy	0.0158	0.0158	CcSEcCtD
Alfuzosin—Angina pectoris—Thalidomide—leprosy	0.0148	0.0148	CcSEcCtD
Alfuzosin—Bronchitis—Thalidomide—leprosy	0.0146	0.0146	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Thalidomide—leprosy	0.0141	0.0141	CcSEcCtD
Alfuzosin—Erectile dysfunction—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Dapsone—leprosy	0.0138	0.0138	CcSEcCtD
Alfuzosin—Infestation NOS—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Alfuzosin—Infestation—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Alfuzosin—Drowsiness—Thalidomide—leprosy	0.0136	0.0136	CcSEcCtD
Alfuzosin—Abdominal pain—Dapsone—leprosy	0.0134	0.0134	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Thalidomide—leprosy	0.0133	0.0133	CcSEcCtD
Alfuzosin—Sweating—Thalidomide—leprosy	0.013	0.013	CcSEcCtD
Alfuzosin—Sinusitis—Thalidomide—leprosy	0.0127	0.0127	CcSEcCtD
Alfuzosin—Rhinitis—Thalidomide—leprosy	0.0122	0.0122	CcSEcCtD
Alfuzosin—Pharyngitis—Thalidomide—leprosy	0.0121	0.0121	CcSEcCtD
Alfuzosin—Urinary tract disorder—Thalidomide—leprosy	0.012	0.012	CcSEcCtD
Alfuzosin—Urethral disorder—Thalidomide—leprosy	0.0119	0.0119	CcSEcCtD
Alfuzosin—Eye disorder—Thalidomide—leprosy	0.0114	0.0114	CcSEcCtD
Alfuzosin—Cardiac disorder—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Alfuzosin—Angiopathy—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Alfuzosin—Mediastinal disorder—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Alfuzosin—Vomiting—Dapsone—leprosy	0.0107	0.0107	CcSEcCtD
Alfuzosin—Mental disorder—Thalidomide—leprosy	0.0107	0.0107	CcSEcCtD
Alfuzosin—Headache—Dapsone—leprosy	0.0106	0.0106	CcSEcCtD
Alfuzosin—Back pain—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Alfuzosin—Nausea—Dapsone—leprosy	0.01	0.01	CcSEcCtD
Alfuzosin—Ill-defined disorder—Thalidomide—leprosy	0.00983	0.00983	CcSEcCtD
Alfuzosin—Angioedema—Thalidomide—leprosy	0.00968	0.00968	CcSEcCtD
Alfuzosin—Malaise—Thalidomide—leprosy	0.00956	0.00956	CcSEcCtD
Alfuzosin—Vertigo—Thalidomide—leprosy	0.00952	0.00952	CcSEcCtD
Alfuzosin—Syncope—Thalidomide—leprosy	0.0095	0.0095	CcSEcCtD
Alfuzosin—Palpitations—Thalidomide—leprosy	0.00936	0.00936	CcSEcCtD
Alfuzosin—Loss of consciousness—Thalidomide—leprosy	0.00931	0.00931	CcSEcCtD
Alfuzosin—Chest pain—Thalidomide—leprosy	0.00902	0.00902	CcSEcCtD
Alfuzosin—Arthralgia—Thalidomide—leprosy	0.00902	0.00902	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.00896	0.00896	CcSEcCtD
Alfuzosin—Discomfort—Thalidomide—leprosy	0.00891	0.00891	CcSEcCtD
Alfuzosin—Dry mouth—Thalidomide—leprosy	0.00882	0.00882	CcSEcCtD
Alfuzosin—Oedema—Thalidomide—leprosy	0.00865	0.00865	CcSEcCtD
Alfuzosin—Infection—Thalidomide—leprosy	0.00859	0.00859	CcSEcCtD
Alfuzosin—Shock—Thalidomide—leprosy	0.00851	0.00851	CcSEcCtD
Alfuzosin—Nervous system disorder—Thalidomide—leprosy	0.00848	0.00848	CcSEcCtD
Alfuzosin—Thrombocytopenia—Thalidomide—leprosy	0.00847	0.00847	CcSEcCtD
Alfuzosin—Tachycardia—Thalidomide—leprosy	0.00844	0.00844	CcSEcCtD
Alfuzosin—Skin disorder—Thalidomide—leprosy	0.0084	0.0084	CcSEcCtD
Alfuzosin—Hyperhidrosis—Thalidomide—leprosy	0.00836	0.00836	CcSEcCtD
Alfuzosin—Hypotension—Thalidomide—leprosy	0.00808	0.00808	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00788	0.00788	CcSEcCtD
Alfuzosin—Somnolence—Thalidomide—leprosy	0.00769	0.00769	CcSEcCtD
Alfuzosin—Dyspepsia—Thalidomide—leprosy	0.00761	0.00761	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Thalidomide—leprosy	0.00747	0.00747	CcSEcCtD
Alfuzosin—Fatigue—Thalidomide—leprosy	0.00746	0.00746	CcSEcCtD
Alfuzosin—Constipation—Thalidomide—leprosy	0.0074	0.0074	CcSEcCtD
Alfuzosin—Pain—Thalidomide—leprosy	0.0074	0.0074	CcSEcCtD
Alfuzosin—Feeling abnormal—Thalidomide—leprosy	0.00713	0.00713	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Thalidomide—leprosy	0.00707	0.00707	CcSEcCtD
Alfuzosin—Urticaria—Thalidomide—leprosy	0.00687	0.00687	CcSEcCtD
Alfuzosin—Abdominal pain—Thalidomide—leprosy	0.00684	0.00684	CcSEcCtD
Alfuzosin—Asthenia—Thalidomide—leprosy	0.0062	0.0062	CcSEcCtD
Alfuzosin—Pruritus—Thalidomide—leprosy	0.00612	0.00612	CcSEcCtD
Alfuzosin—Diarrhoea—Thalidomide—leprosy	0.00592	0.00592	CcSEcCtD
Alfuzosin—Dizziness—Thalidomide—leprosy	0.00572	0.00572	CcSEcCtD
Alfuzosin—Vomiting—Thalidomide—leprosy	0.0055	0.0055	CcSEcCtD
Alfuzosin—Rash—Thalidomide—leprosy	0.00545	0.00545	CcSEcCtD
Alfuzosin—Dermatitis—Thalidomide—leprosy	0.00545	0.00545	CcSEcCtD
Alfuzosin—Headache—Thalidomide—leprosy	0.00542	0.00542	CcSEcCtD
Alfuzosin—Nausea—Thalidomide—leprosy	0.00514	0.00514	CcSEcCtD
